Author information from the last article
Andreas Wahl Blomkvist er spesialist i rus- og avhengighetsmedisin og ph.d.-stipendiat. Han jobber som overlege ved Rusavdelingen, Universitetssykehuset Nord-Norge.
Articles by Andreas Wahl Blomkvist
Need for evidence-based approach to benzodiazepine dependence in opioid agonist treatment
- Fatemeh Chalabianloo,
- John Fredrik Askjer,
- Andreas Wahl Blomkvist,
- Kjetil Samuel Dale,
- Christine Sundal,
- Beathe Hauge Rønning,
- Wasifa Sofia Javed Butt,
- Silvia Zavenova,
- Anne Gry Ørmen,
- Christina Dahl Andersen,
- Kjell Arne Johansson,
- Lars Thore Fadnes,
- Jon Mordal
15.04.2026:
When repeated attempts to taper benzodiazepines are unsuccessful, clinicians face a dilemma: should the ideal of recovery remain the goal? Patients attending opioid agonist treatment (OAT) clinics in Norway often struggle with anxiety, insomnia, trauma and withdrawal symptoms. Many have used...
Norwegian Medical Association should represent members' views on assisted dying
- Andreas Wahl Blomkvist,
- Pia Zadig,
- Edvin Schei,
- Gro Nylander,
- Carl Tollef Solberg,
- Martin Ryssdal,
- Filip Stojanovic,
- Wasim Zahid,
- Synne Bernhard
23.06.2022:
A growing number of doctors in Norway no longer support the Norwegian Medical Association's view on assisted dying. A number of medical associations internationally have taken a neutral stance. The Norwegian Medical Association should consider doing the same. In line with changes in public opinion...
Ketamine for depression – evidence and proposals for practice
- Tor-Morten Kvam,
- Lowan H. Stewart,
- Andreas Wahl Blomkvist,
- Ole A. Andreassen
25.10.2021:
Current treatment for serious depression is unsatisfactory, and many patients fail to achieve the desired effect. Ketamine represents a new treatment option, and randomised trials show a rapid effect of intravenous ketamine. Although knowledge about adverse effects and the duration of the effect is...